GHG Emissions, Industrial, Solar  -  June 26, 2024

Kenvue Increases RE, Lowers Emissions

Kenvue Inc., a consumer health products company, announced that investments in energy efficiency and decarbonization projects have resulted in Scope 1 and 2 GHG reductions of 26% since 2020.

The company — which manufactures iconic brands including Aveeno®, BAND-AID® Brand, Johnson’s®, Listerine®, Neutrogena® and Tylenol® — also increased its use of renewable electricity to 65% through 18 onsite solar-powered electricity systems and offsite renewable electricity procurement contracts.

The company committed to reduce absolute Scope 1 and 2 GHG emissions by 42% by 2030 from a 2020 base year, also  committing that 75% of its suppliers by emissions covering purchased goods and services and upstream transportation and distribution will have science-based targets by 2028.

The company set long-term net zero emission targets informed by the SBTi Net Zero Standard18 and plans to achieve 100% renewable electricity for its operations by 2030.

Details were released in its first-ever Healthy Lives Mission Report.

“In the past year, we have made meaningful progress with our Healthy Lives Mission, reduced our greenhouse gas (GHG) emissions and virgin plastic footprint, advanced the sustainable sourcing of paper, and developed values-led policies and programs to positively impact individuals and communities,” said Pamela Gill-Alabaster, Global Head of ESG & Sustainability, in a statement. “As a global leader in consumer health, we will continue to draw on our brands, resources and platforms to help shape a healthy future for both people and planet.”